Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

PRHSX vs FSPHX overlap: 49% of top holdings shared

Bottom line

How much do PRHSX and FSPHX overlap?

49% of their top holdings overlap by weight. 12 securities appear in both funds' top 25, making up 46.8% of PRHSX's assets and 38.4% of FSPHX's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

PRHSXFSPHX
Weight overlap (top 25)49%
Shared holdings12
Weight in shared holdings46.8%38.4%
Total positions279152
Expense ratio0.83%0.62%
Holdings as ofJun 30, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Holdings PRHSX and FSPHX have in common

Holding% of PRHSX% of FSPHXOverlap
Eli Lilly & Co14.28%8.03%8.03%
Johnson & Johnson6.63%4.91%4.91%
Unitedhealth Group Inc5.99%3.49%3.49%
Abbvie Inc5.10%2.03%2.03%
Merck & Co. Inc.4.01%1.60%1.60%
Gilead Sciences Inc2.82%2.21%2.21%
Thermo Fisher Scientific Inc2.52%4.33%2.52%
Natera Inc1.44%1.27%1.27%
Danaher Corp1.43%6.89%1.43%
Cvs Health Corp0.94%1.29%0.94%
Moderna Therapeutics Inc0.83%1.18%0.83%
Brightspring Health Services0.82%1.23%0.82%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in PRHSX

  1. Vertex Pharmaceuticals Inc — 2.28%
  2. Bristol-myers Squibb Co — 2.11%
  3. Abbott Laboratories — 1.89%
  4. Intuitive Surgical Inc — 1.87%
  5. Amgen Inc — 1.82%
  6. Stryker Corp — 1.78%
  7. Elevance Health Inc — 1.53%
  8. Guardant Health Inc — 1.23%
  9. Cardinal Health Inc — 1.03%
  10. Royalty Pharma Plc- Cl A — 0.97%
  11. Tenet Healthcare Corp — 0.94%
  12. Kymera Therapeutics Inc — 0.89%
  13. Protagonist Therapeutics Inc — 0.85%

Only in FSPHX

  1. Alnylam Pharmaceuticals Inc — 2.40%
  2. Boston Scientific Corp — 2.17%
  3. Ascendis Pharma A/s — 2.17%
  4. Fidelity Revere Street Trust — 2.17%
  5. Ucb Sa — 2.03%
  6. Bio Techne Corp — 1.70%
  7. Argenx Se — 1.56%
  8. Nuvalent Inc — 1.28%
  9. Viatris Inc — 1.20%
  10. Cencora Inc — 1.14%
  11. West Pharmaceutical Svcs Inc — 1.12%
  12. Agilent Technologies Inc — 1.10%
  13. Edwards Lifesciences Corp — 1.09%

Asset mix

Asset typePRHSXFSPHX
Stocks96.4%97.7%
Preferred stock3.0%2.0%
Cash & short-term funds0.7%2.4%
Bonds0.2%0.1%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Country mix

CountryPRHSXFSPHX
US92.6%87.0%
NL1.0%2.4%
DK0.7%2.2%
GB1.7%2.1%
BE—2.0%
CH0.5%1.4%
KY0.5%1.4%
CA0.6%1.1%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Check another pair

FAQ

How much do PRHSX and FSPHX overlap?
About 49% by weight. 12 securities appear in both funds' top 25 holdings; they make up 46.8% of PRHSX's assets and 38.4% of FSPHX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do PRHSX and FSPHX have in common?
The largest shared holdings are Eli Lilly & Co, Johnson & Johnson, Unitedhealth Group Inc, Thermo Fisher Scientific Inc, Gilead Sciences Inc.
Should I own both PRHSX and FSPHX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, PRHSX or FSPHX?
PRHSX is broader, with 279 positions versus 152 for FSPHX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.